SCHEMBL20166093

SCHEMBL20166093

CCCCOC(=O)N(C)CCCC(=O)O

nearest known ligand 0.49

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
EPHX2 P34913 5/20 0.49
AKR1B1 P15121 1/20 0.45
GPR84 Q9NQS5 7/20 0.44
PPARG P37231 7/20 0.44
PPARD Q03181 7/20 0.44
PPARA Q07869 7/20 0.44
HDAC11 Q96DB2 5/20 0.44
TSHR P16473 4/20 0.44
PTPN1 P18031 3/20 0.44
ALDH1A1 P00352 3/20 0.44
TLR2 O60603 2/20 0.44
TDP1 Q9NUW8 2/20 0.44
FABP4 P15090 2/20 0.44
SLC22A6 Q4U2R8 1/20 0.44
SLC22A8 Q8TCC7 1/20 0.44
MEN1 O00255 1/20 0.44
ESR1 P03372 1/20 0.44
ALOX15 P16050 1/20 0.44
PDE4A P27815 1/20 0.44
KMT2A Q03164 1/20 0.44

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1759123 0.91 ALDH1A1 (0.44) EPHX2AKR1B1GPR84PPARGPPARD
SCHEMBL25565603 0.87 ALDH1A1 (0.50) TSHRALDH1A1TDP1ESR1
SCHEMBL30195730 0.82 ALDH1A1 (0.45) TSHRALDH1A1TDP1ESR1
SCHEMBL2870267 0.82 CHRNB2 (0.47) TSHRALDH1A1TDP1ESR1
SCHEMBL11785064 0.82 NAAA (0.48) EPHX2TSHRALDH1A1
SCHEMBL29008686 0.81 ALDH1A1 (0.44) EPHX2TSHRALDH1A1TDP1ESR1
SCHEMBL27900231 0.81 ALDH1A1 (0.44) TSHRALDH1A1TDP1ESR1
SCHEMBL30353308 0.81 CHRNB2 (0.46) EPHX2TSHRALDH1A1MEN1KMT2A
SCHEMBL31113595 0.81 ALDH1A1 (0.44) TSHRALDH1A1TDP1ESR1HSD17B10
SCHEMBL2291415 0.80 ALDH1A1 (0.47) AKR1B1TSHRALDH1A1TDP1ESR1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-4440702-A1 THERAPEUTIC COMPOUNDS FOR HIV VIRUS INFECTION GILEAD SCIENCES, INC. (US) 2024-10-09 EP disclosed
WO-2023102239-A1 THERAPEUTIC COMPOUNDS FOR HIV VIRUS INFECTION GILEAD SCIENCES, INC. (US) 2023-06-08 WO disclosed
EP-3541857-A1 CATALYST COMPONENTS FOR THE POLYMERIZATION OF OLEFINS Basell Poliolefine Italia S.r.l. (IT) 2019-09-25 EP disclosed
WO-2018091375-A1 CATALYST COMPONENTS FOR THE POLYMERIZATION OF OLEFINS BASELL POLIOLEFINE ITALIA S.R.L. (IT) 2018-05-24 WO disclosed